Jan 6 (Reuters) - Predictive Oncology Inc :
* PREDICTIVE ONCOLOGY ANNOUNCES AGREEMENT TO BE ACQUIRED BY RENOVARO
* PREDICTIVE ONCOLOGY INC - MERGER EXPECTED TO REDUCE OPERATING EXPENSES BY OVER 30%
* PREDICTIVE ONCOLOGY INC - PREFERRED STOCK ISSUED IN 1:1 EXCHANGE FOR PREDICTIVE ONCOLOGY COMMON STOCK
* PREDICTIVE ONCOLOGY INC - RENOVARO CAN REDEEM PREFERRED STOCK FOR $3.00 PER SHARE
Source text: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.